» Articles » PMID: 35114279

Genetic Profiles of Non-syndromic Severe-profound Hearing Loss in Chinese Hans by Whole-exome Sequencing

Overview
Journal Gene
Specialty Molecular Biology
Date 2022 Feb 3
PMID 35114279
Authors
Affiliations
Soon will be listed here.
Abstract

Hereditary hearing loss is highly heterogeneous. Despite over 120 non-syndromic deafness genes have been identified, there are still some of novel genes and variants being explored. In the study, we investigated 105 Chinese Han children with non-syndromic, prelingual, severe-profound hearing loss by whole-exome sequencing on DNA samples. The most common deafness gene was GJB2, mainly in variant c.235delC (p.Leu79CysfsTer3). 14 children were identified with pathogenic mutations in three genes, GJB2, SLC26A4, and OTOF. Two mutations have been identified to be pathogenic and not recorded previously, including c.4691G > A (p.Trp1564Ter) and c.3928_3930dup (p.Lys1310dup) in OTOF. The rare variants c.1349G > A (p.Arg450His) and c.456 T > G (p.Asn152Lys) in GSDME, and c.1595G > T (p.Ser532Ile) in SLC26A4 were detected. The frequency of nonsense variant c.2359G > T (p.Glu787Ter) in OTOA was very high in 17 cases. Four of them were identified to be digenic inheritance, including GJB2 and COL4A4, GJB2 and EYA1, GJB2 and COL4A5, and GJB2 and DFNA5. The findings showed that a novel pathogenic variant and rare variants may be associated with severe and profound hearing loss.

Citing Articles

Genetic landscape in undiagnosed patients with syndromic hearing loss revealed by whole exome sequencing and phenotype similarity search.

Mutai H, Miya F, Nara K, Yamamoto N, Inoue S, Murakami H Hum Genet. 2025; 144(1):93-112.

PMID: 39755840 DOI: 10.1007/s00439-024-02719-5.


Functional pathogenicity of ESRRB variant of uncertain significance contributes to hearing loss (DFNB35).

Choi W, Cho Y, Cha J, Lee D, Jeong J, Jung S Sci Rep. 2024; 14(1):21215.

PMID: 39261511 PMC: 11390957. DOI: 10.1038/s41598-024-70795-8.


Comprehensive analysis, diagnosis, prognosis, and cordycepin (CD) regulations for GSDME expressions in pan-cancers.

Fu J, Li D, Zhang L, Maghsoudloo M, Cheng J, Fu J Cancer Cell Int. 2024; 24(1):279.

PMID: 39118110 PMC: 11312966. DOI: 10.1186/s12935-024-03467-2.


A novel splice-altering TNC variant (c.5247A > T, p.Gly1749Gly) in an Chinese family with autosomal dominant non-syndromic hearing loss.

He M, Hu M, Zhang Q, Yao K BMC Med Genomics. 2024; 17(1):189.

PMID: 39020321 PMC: 11256465. DOI: 10.1186/s12920-024-01964-x.


Novel, pathogenic insertion variant of GSDME associates with autosomal dominant hearing loss in a large Chinese pedigree.

Cheng J, Li T, Tan Q, Fu J, Zhang L, Yang L J Cell Mol Med. 2023; 28(1):e18004.

PMID: 37864300 PMC: 10805510. DOI: 10.1111/jcmm.18004.